Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Tuberculosis

  Free Subscription


21.10.2019

1 AIDS
1 Antimicrob Agents Chemother
2 Clin Infect Dis
1 Eur J Clin Microbiol Infect Dis
4 Eur Respir J
11 Int J Tuberc Lung Dis
1 J Clin Microbiol
1 J Immunol
1 J Infect Dis
1 Lancet Glob Health
2 Lancet Respir Med
2 PLoS One
1 Respir Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. KROEZE S, Ondoa P, Kityo CM, Siwale M, et al
    Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001801.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  2. DONNELLAN S, Aljayyoussi G, Moyo E, Ardrey A, et al
    Intracellular pharmacodynamic modelling (PDi) is predictive of the clinical activity of fluoroquinolones against Tuberculosis.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.00989.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  3. LACOURSE SM, Cranmer LM, Njuguna IN, Gatimu J, et al
    Urine TB lipoarabinomannan (LAM) predicts mortality in hospitalized HIV-infected children.
    Clin Infect Dis. 2018 Jan 6. pii: 4792803. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. NAIDOO K, Hassan-Moosa R, Mlotshwa P, Yende-Zuma N, et al
    High Rates of Drug-induced Liver Injury in People Living With HIV Coinfected With Tuberculosis (TB) Irrespective of Antiretroviral Therapy Timing During Antituberculosis Treatment: Results From the Starting Antiretroviral Therapy at Three Points in TB
    Clin Infect Dis. 2019 Oct 17. pii: 5589114. doi: 10.1093.
    PubMed     Text format     Abstract available


    Eur J Clin Microbiol Infect Dis

  5. SAAD J, Loukil A, Drancourt M
    Bead-captured Mycobacterium tuberculosis for next-generation sequencing diagnosis of uncultured tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2019 Oct 14. pii: 10.1007/s10096-019-03700.
    PubMed     Text format    


    Eur Respir J

  6. CAMINERO JA, Garcia-Basteiro AL, Rendon A, Piubello A, et al
    The future of drug-resistant tuberculosis treatment: learning from the past and the 2019 World Health Organization consolidated guidelines.
    Eur Respir J. 2019;54.
    PubMed     Text format    

  7. DIEL R, Schluger NW
    Is adding fluoroquinolones to regimens for treating isoniazid-resistant tuberculosis necessary?
    Eur Respir J. 2019;54.
    PubMed     Text format    

  8. OLAYANJU O, Esmail A, Limberis J, Dheda K, et al
    A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug resistant tuberculosis.
    Eur Respir J. 2019 Oct 16. pii: 13993003.01181-2019.
    PubMed     Text format     Abstract available

  9. BORISOV S, Danila E, Maryandyshev A, Dalcolmo M, et al
    Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.
    Eur Respir J. 2019 Oct 10. pii: 13993003.01522-2019.
    PubMed     Text format     Abstract available


    Int J Tuberc Lung Dis

  10. ZHANG HC, Ruan QL, Wu J, Zhang S, et al
    Serial T-SPOT.TB in household contacts of tuberculosis patients: a 6-year observational study in China.
    Int J Tuberc Lung Dis. 2019;23:989-995.
    PubMed     Text format     Abstract available

  11. HELD K, McAnaw S, Chiang CY, Trebucq A, et al
    Progress in global rollout of new multidrug-resistant tuberculosis treatments.
    Int J Tuberc Lung Dis. 2019;23:996-999.
    PubMed     Text format     Abstract available

  12. OTA M, Uchimura K
    Trends of tuberculosis rates before and after the declaration as a public health emergency in Japan, 1992-2006.
    Int J Tuberc Lung Dis. 2019;23:1000-1004.
    PubMed     Text format     Abstract available

  13. DI BELLA S, Siroka A, Antonello RM, Zignol M, et al
    Tuberculosis screening in outpatient healthcare workers: lessons from a high-income, low TB burden country.
    Int J Tuberc Lung Dis. 2019;23:1024-1028.
    PubMed     Text format     Abstract available

  14. FARLEY JE, McKenzie-White J, Bollinger R, Hong H, et al
    Evaluation of miLINC to shorten time to treatment for rifampicin-resistant Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:980-988.
    PubMed     Text format     Abstract available

  15. SMITTIPAT N, Miyahara R, Juthayothin T, Billamas P, et al
    Indo-Oceanic Mycobacterium tuberculosis strains from Thailand associated with higher mortality.
    Int J Tuberc Lung Dis. 2019;23:972-979.
    PubMed     Text format     Abstract available

  16. BUZIASHVILI M, Mirtskhulava V, Kipiani M, Blumberg HM, et al
    Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, Georgia.
    Int J Tuberc Lung Dis. 2019;23:1005-1011.
    PubMed     Text format     Abstract available

  17. PEREA-JACOBO R, Muniz-Salazar R, Laniado-Laborin R, Cabello-Pasini A, et al
    Rifampin pharmacokinetics in tuberculosis-diabetes mellitus patients: a pilot study from Baja California, Mexico.
    Int J Tuberc Lung Dis. 2019;23:1012-1016.
    PubMed     Text format     Abstract available

  18. HUGHES J, Reuter A, Chabalala B, Isaakidis P, et al
    Adverse events among people on delamanid for rifampicin-resistant tuberculosis in a high HIV prevalence setting.
    Int J Tuberc Lung Dis. 2019;23:1017-1023.
    PubMed     Text format     Abstract available

  19. GALEGO MA, Santos JV, Viana J, Freitas A, et al
    To be or not to be hospitalised with tuberculosis in Portugal.
    Int J Tuberc Lung Dis. 2019;23:1029-1034.
    PubMed     Text format     Abstract available

  20. VANINO E, Tadolini M, Attard L, Cascavilla A, et al
    A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care.
    Int J Tuberc Lung Dis. 2019;23:1042.
    PubMed     Text format    


    J Clin Microbiol

  21. LISBOA VDC, Ribeiro-Alves M, Correa RDS, Lopes IR, et al
    The predominance of Th1 Immune Response in Pleural Effusion of Patients with Tuberculosis Among Other Exudative Etiologies.
    J Clin Microbiol. 2019 Oct 16. pii: JCM.00927-19. doi: 10.1128/JCM.00927.
    PubMed     Text format     Abstract available


    J Immunol

  22. PADHI A, Pattnaik K, Biswas M, Jagadeb M, et al
    Mycobacterium tuberculosis LprE Suppresses TLR2-Dependent Cathelicidin and Autophagy Expression to Enhance Bacterial Survival in Macrophages.
    J Immunol. 2019 Oct 16. pii: jimmunol.1801301. doi: 10.4049/jimmunol.1801301.
    PubMed     Text format     Abstract available


    J Infect Dis

  23. DUTTA NK, Bruiners N, Zimmerman MD, Tan S, et al
    Adjunctive host-directed therapy with statins improves tuberculosis-related outcomes in mice.
    J Infect Dis. 2019 Oct 12. pii: 5586531. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  24. REID M, Von Zinkernagel D, Beyeler N, Goosby E, et al
    Global Fund replenishment brings us one step closer to ending tuberculosis.
    Lancet Glob Health. 2019 Oct 9. pii: S2214-109X(19)30424.
    PubMed     Text format    


    Lancet Respir Med

  25. MUSHTAQ A
    Breakthrough in the treatment of drug-resistant tuberculosis.
    Lancet Respir Med. 2019 Oct 10. pii: S2213-2600(19)30376.
    PubMed     Text format    

  26. SHARMA DC
    India launches tuberculosis prevalence survey.
    Lancet Respir Med. 2019 Oct 10. pii: S2213-2600(19)30377.
    PubMed     Text format    


    PLoS One

  27. BOUTON TC, de Vos M, Ragan EJ, White LF, et al
    Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis.
    PLoS One. 2019;14:e0223308.
    PubMed     Text format     Abstract available

  28. TAGHIPOUR A, Mosadegh M, Kheirollahzadeh F, Olfatifar M, et al
    Are intestinal helminths playing a positive role in tuberculosis risk? A systematic review and meta-analysis.
    PLoS One. 2019;14:e0223722.
    PubMed     Text format     Abstract available


    Respir Med

  29. HUANG CT, Lee MR, Ruan SY, Tsai YJ, et al
    Prognostic value of the mitogen response in the interferon-gamma release assay in patients with culture-confirmed tuberculosis.
    Respir Med. 2019;158:49-54.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: